share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Dubovsky Filip

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Dubovsky Filip

諾瓦瓦克斯醫藥 | 4：持股變動聲明-高管 Dubovsky Filip
美股sec公告 ·  05/16 09:21
牛牛AI助理已提取核心訊息
On May 14, 2024, Novavax's President of R&D, Filip Dubovsky, completed a significant transaction involving the company's common stock. Dubovsky executed a sale of 47,312 shares at a price of $13.90 per share, resulting in a total market value of $657,636.80. Prior to this sale, Dubovsky acquired 19,652 shares through the exercise of derivative securities at a price of $6.97 each. Following these transactions, Dubovsky's direct holdings in Novavax amounted to 38,953 shares of common stock.
On May 14, 2024, Novavax's President of R&D, Filip Dubovsky, completed a significant transaction involving the company's common stock. Dubovsky executed a sale of 47,312 shares at a price of $13.90 per share, resulting in a total market value of $657,636.80. Prior to this sale, Dubovsky acquired 19,652 shares through the exercise of derivative securities at a price of $6.97 each. Following these transactions, Dubovsky's direct holdings in Novavax amounted to 38,953 shares of common stock.
2024年5月14日，Novavax的研發總裁菲利普·杜波夫斯基完成了一項涉及公司普通股的重大交易。杜波夫斯基以每股13.90美元的價格出售了47,312股股票，總市值爲657,636.80美元。在此次出售之前，杜波夫斯基通過行使衍生證券以每股6.97美元的價格收購了19,652股股票。這些交易之後，杜波夫斯基在Novavax的直接持有量爲38,953股普通股。
2024年5月14日，Novavax的研發總裁菲利普·杜波夫斯基完成了一項涉及公司普通股的重大交易。杜波夫斯基以每股13.90美元的價格出售了47,312股股票，總市值爲657,636.80美元。在此次出售之前，杜波夫斯基通過行使衍生證券以每股6.97美元的價格收購了19,652股股票。這些交易之後，杜波夫斯基在Novavax的直接持有量爲38,953股普通股。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。